Biostage, Inc.·4

Jan 5, 2:26 PM ET

He Junli 4

4 · Biostage, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2022-12-12
He Junli
DirectorCEO
Transactions
  • Sale

    Common Stock

    2022-12-12$6.83/sh135$922235,000 total

Documents

1 file
  • 4
    form4-01052023_070112.xmlPrimary